目次

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape

2 Market Overview
2.1. Market definition
2.2. Market analysis

3 Market Data
3.1. Market value

4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation

5 Market Outlook
5.1. Market value forecast

6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. Has there been any recent M&A activity in the market?

8 Company Profiles
8.1. Novartis AG
8.2. Bayer AG
8.3. AstraZeneca PLC
8.4. BioNTech SE

9 Macroeconomic Indicators
9.1. Country data

10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List of Tables
Table 1: Europe biotechnology industry value: $ billion, 2017-22
Table 2: Europe biotechnology industry category segmentation: % share, by value, 2017-2022
Table 3: Europe biotechnology industry category segmentation: $ billion, 2017-2022
Table 4: Europe biotechnology industry geography segmentation: $ billion, 2022
Table 5: Europe biotechnology industry value forecast: $ billion, 2022-27
Table 6: Novartis AG: key facts
Table 7: Novartis AG: Annual Financial Ratios
Table 8: Novartis AG: Key Employees
Table 9: Novartis AG: Key Employees Continued
Table 10: Bayer AG: key facts
Table 11: Bayer AG: Annual Financial Ratios
Table 12: Bayer AG: Key Employees
Table 13: Bayer AG: Key Employees Continued
Table 14: AstraZeneca PLC: key facts
Table 15: AstraZeneca PLC: Annual Financial Ratios
Table 16: AstraZeneca PLC: Key Employees
Table 17: AstraZeneca PLC: Key Employees Continued
Table 18: BioNTech SE: key facts
Table 19: BioNTech SE: Annual Financial Ratios
Table 20: BioNTech SE: Key Employees
Table 21: Europe size of population (million), 2018-22
Table 22: Europe gdp (constant 2005 prices, $ billion), 2018-22
Table 23: Europe gdp (current prices, $ billion), 2018-22
Table 24: Europe inflation, 2018-22
Table 25: Europe consumer price index (absolute), 2018-22
Table 26: Europe exchange rate, 2018-22

List of Figures
Figure 1: Europe biotechnology industry value: $ billion, 2017-22
Figure 2: Europe biotechnology industry category segmentation: $ billion, 2017-2022
Figure 3: Europe biotechnology industry geography segmentation: % share, by value, 2022
Figure 4: Europe biotechnology industry value forecast: $ billion, 2022-27
Figure 5: Forces driving competition in the biotechnology industry in Europe, 2022
Figure 6: Drivers of buyer power in the biotechnology industry in Europe, 2022
Figure 7: Drivers of supplier power in the biotechnology industry in Europe, 2022
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Europe, 2022
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Europe, 2022
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Europe, 2022